Restrictive cardiomyopathy
KEYWORDS: cardiomyopathy, restrictive, restrictive cardiomyopathy, disease, amyloidosis, heart, patients, symptoms, normal, history, common, cardiac, include, symptom, hemochromatosis

also the common causes. Cardiac genes for desmin, Î±-actin, troponin I and troponin T are involved in the pathogenesis of restrictive cardiomyopathy. Restrictive cardiomyopathy should be differentiated from dilated cardiomyopathy, hypertrophic cardiomyopathy, congestive heart failure. Restrictive cardiomyopathy is very rare among all other types and accounts for approximately 5% of all cases. Its prevalence varies depending on regionality, ethnicity, age, and gender. Amyloidosis affects men and women equally. The wild-type transthyretin amyloidosis is most often found in the elderly population. Common complications of restrictive cardiomyopathy include thromboembolism, rhythm abnormalities(dysrhythmias), cardiac cirrhosis, heart failure, pulmonary hypertension. Common symptoms include dyspnea, fatigue, palpitations, syncope. Jugular venous distension is noted sometimes with Kussmaul sign and Hepatojugular reflux.S3 and S4 gallops seen. ECG shows Low QRS voltages, conduction disturbances, nonspecific ST abnormalities. Transmitral spectral Doppler often shows restrictive filling pattern and Ejection fraction (EF) is normal. The main purpose of treatment in restrictive cardiomyopathy (RCM) is to reduce symptoms by decreasing the elevated filling pressures without significantly lowering the cardiac output.Pharmacologic therapy may include Beta blockers, Amiodarone, Cardioselective [[calcium channel blockers], Diuretics, Anticoagulants for patients with atrial fibrillation, Melphalan (for antiplasma cell therapy in systemic amyloidosis), Chemotherapy (in amyloidosis). Other approaches like Pacemaker implantation
